Ipilimumab with fotemustine in metastatic melanoma

被引：5
|
作者：
Garbe, Claus [1 ]
机构：
[1] Univ Med Ctr, Dept Dermatol, Div Dermatooncol, D-72074 Tubingen, Germany
来源：
LANCET ONCOLOGY | 2012年 / 13卷 / 09期
关键词：
DISSEMINATED MALIGNANT-MELANOMA; DACARBAZINE; THERAPY;
D O I：
10.1016/S1470-2045(12)70341-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：851 / 852
页数：3
相关论文
共 50 条
  • [1] IPILIMUMAB FOR METASTATIC MELANOMA
    Ozao-Choy, J.
    Carvajal, R. D.
    Hamid, O.
    [J]. DRUGS OF TODAY, 2012, 48 (06) : 381 - 393
  • [2] Metastatic Melanoma and Ipilimumab
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 777 - 777
  • [3] Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial
    Di Giacomo, A. M.
    Sileni, V. Chiarion
    Del Vecchio, M.
    Ferrucci, P. F.
    Guida, M.
    Quaglino, P.
    Guidoboni, M.
    Marchetti, P.
    Cutaia, O.
    Amato, G.
    Gambale, E.
    Calabro, L.
    Valente, M.
    Danielli, R.
    Giannarelli, D.
    Mandala, M.
    Maio, M.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S734 - S734
  • [4] A randomized, phase III study of fotemustine versus the combination of fotemustine and ipilimumab or the combination of ipilimumab and nivolumab in patients with metastatic melanoma with brain metastasis: the NIBIT-M2 trial.
    Di Giacomo, Anna Maria
    Annesi, Diego
    Ascierto, Paolo Antonio
    Calabro, Luana
    Chiarion-Sileni, Vanna
    Danielli, Riccardo
    Del Vecchio, Michele
    Ferraresi, Virginia
    Ferrucci, Pier Francesco
    Fonsatti, Ester
    Guida, Michele
    Giannarelli, Diana
    Guidoboni, Massimo
    Mandala, Mario
    Quaglino, Pietro
    Queirolo, Paola
    Maccalli, Cristina
    Parmiani, Giorgio
    Maio, Michele
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] A Phase II Study Combining Ipilimumab and Fotemustine in Patients With Metastatic Melanoma - the NIBIT-M1 Trial
    Di Giacomo, A. M.
    Ascierto, P. A.
    Pittiglio, E.
    Queirolo, P.
    Pilla, L.
    Ridolfi, R.
    Santinami, M.
    Testori, A.
    Parmiani, G.
    Maio, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S653 - S654
  • [6] Treatment of metastatic uveal melanoma with intravenous fotemustine
    Spagnolo, Francesco
    Grosso, Marco
    Picasso, Virginia
    Tornari, Elena
    Pesce, Marianna
    Queirolo, Paola
    [J]. MELANOMA RESEARCH, 2013, 23 (03) : 196 - 198
  • [7] Temozolomide in combination with fotemustine in patients with metastatic melanoma
    Tas, Faruk
    Camlica, Hakan
    Topuz, Erkan
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 293 - 298
  • [8] Temozolomide in combination with fotemustine in patients with metastatic melanoma
    Faruk Tas
    Hakan Camlica
    Erkan Topuz
    [J]. Cancer Chemotherapy and Pharmacology, 2008, 62 : 293 - 298
  • [9] Ipilimumab approved for metastatic melanoma
    Traynor, Kate
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (09) : 768 - 768
  • [10] Ipilimumab for metastatic uveal melanoma
    Gilbert, Judith A.
    [J]. LANCET ONCOLOGY, 2013, 14 (10): : E394 - E394
12345